Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.
This report covers the present status and the future prospects of the global Binge Eating Disorder Drug market for 2015-2026.
The report offers detailed coverage of Binge Eating Disorder Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Binge Eating Disorder Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals, Opiant Pharmaceuticals
Market Segment as follows:
Market by Order Type
Antidepressants
Anticonvulsants
Anti-obesity Medications
Market Size Split by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
market while maintaining their competitive edge over their competitors. The report offers detailed and crucial information to understand the overall market scenario.
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Binge Eating Disorder Drug market for the forecast period 2021 - 2026?
• What are the driving forces in the Binge Eating Disorder Drug market for the forecast period 2021 - 2026?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Binge Eating Disorder Drug industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.